Search results
Results from the WOW.Com Content Network
Alnylam to Webcast Presentation at Upcoming Investor Conferences CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (NAS: ALNY) , a leading RNAi therapeutics company, today ...
In this article we will take a look at whether hedge funds think Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a good investment right now. We check hedge fund and billionaire investor sentiment ...
Alnylam to Webcast Presentation at 2013 Bank of America Merrill Lynch Health Care Conference CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (NAS: ALNY) , a leading RNAi ...
Alnylam to Webcast Presentation at 20 th Annual NewsMakers in the Biotech Industry Conference CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (NAS: ALNY) , a leading RNAi ...
In 2002, Alnylam was founded by scientists Phillip Sharp, Paul Schimmel, David Bartel, Thomas Tuschl, and Phillip Zamore, and by investors Christoph Westphal and John Kennedy Clarke; John Maraganore was the founding CEO. [5] [7] [8] The company was named after Alnilam, a star in Orion's belt. The spelling was modified to make it unique. [9]
Alnylam to Webcast Presentation at Deutsche Bank 38 th Annual dbAccess Health Care Conference CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (NAS: ALNY) , a leading RNAi ...
Alnylam to Webcast Presentation at Cowen and Company 33 rd Annual Health Care Conference CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (NAS: ALNY) , a leading RNAi therapeutics ...
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...